Loading company…
Sprint Bioscience develops drug candidates for cancer treatment.
Sprint Bioscience uses fragment-based drug development to create oncology candidates. It works with biotechnology and pharmaceutical companies through partnerships and licensing agreements. Founded in 2009, the company is based in Stockholm, Sweden. On October 19, 2012, it raised SEK 2.000 mn from ALMI Invest and First Entrepreneurs Fund.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in